Cassava Sciences Inc (SAVA)
32.18
+6.13
(+23.53%)
USD |
NASDAQ |
Nov 21, 16:00
34.49
+2.31
(+7.18%)
After-Hours: 04:45
Cassava Sciences Net Income (Quarterly): -27.94M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -27.94M |
| June 30, 2024 | 6.155M |
| March 31, 2024 | 25.04M |
| December 31, 2023 | -20.92M |
| September 30, 2023 | -25.65M |
| June 30, 2023 | -26.38M |
| March 31, 2023 | -24.27M |
| December 31, 2022 | -19.13M |
| September 30, 2022 | -20.26M |
| June 30, 2022 | -19.33M |
| March 31, 2022 | -17.53M |
| December 31, 2021 | -14.17M |
| September 30, 2021 | -9.562M |
| June 30, 2021 | -5.125M |
| March 31, 2021 | -3.526M |
| December 31, 2020 | -2.618M |
| September 30, 2020 | -1.43M |
| June 30, 2020 | -1.136M |
| March 31, 2020 | -1.15M |
| December 31, 2019 | -1.516M |
| September 30, 2019 | -0.697M |
| June 30, 2019 | -1.059M |
| March 31, 2019 | -1.359M |
| December 31, 2018 | -0.677M |
| September 30, 2018 | -1.267M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.452M |
| March 31, 2018 | -2.16M |
| December 31, 2017 | -2.418M |
| September 30, 2017 | -2.59M |
| June 30, 2017 | -4.16M |
| March 31, 2017 | -2.743M |
| December 31, 2016 | -2.522M |
| September 30, 2016 | -3.518M |
| June 30, 2016 | -3.015M |
| March 31, 2016 | -5.795M |
| December 31, 2015 | -4.517M |
| September 30, 2015 | -3.671M |
| June 30, 2015 | -3.374M |
| March 31, 2015 | -2.583M |
| December 31, 2014 | -2.156M |
| September 30, 2014 | -3.534M |
| June 30, 2014 | -3.246M |
| March 31, 2014 | -3.45M |
| December 31, 2013 | 33.02M |
| September 30, 2013 | -0.762M |
| June 30, 2013 | -0.301M |
| March 31, 2013 | -0.408M |
| December 31, 2012 | -1.794M |
| September 30, 2012 | -1.55M |
| June 30, 2012 | -0.13M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-27.94M
Minimum
Sep 2024
25.04M
Maximum
Mar 2024
-10.52M
Average
-11.87M
Median
Net Income (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 1.211B |
| Seelos Therapeutics Inc | 1.71M |
| EyePoint Pharmaceuticals Inc | -29.36M |
| PTC Therapeutics Inc | -106.65M |
| Adverum Biotechnologies Inc | -27.13M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 30.62M |
| EPS Diluted (Quarterly) | -0.58 |
| Enterprise Value | 1.399B |
| Earnings Yield | -4.29% |
| Operating Earnings Yield | 2.16% |
| Normalized Earnings Yield | 14.79 |